ChemicalBook > CAS DataBase List > UMiroliMus

UMiroliMus

Product Name
UMiroliMus
CAS No.
851536-75-9
Chemical Name
UMiroliMus
Synonyms
TRM986;TRM 986;TRM-986;BioliMus;UMiroliMus;BIOLIMUS A9;BioliMus A9 UMiroliMus;BioliMus, BioliMus A9, TRM 986;Rapamycin, 42-O-(2-ethoxyethyl)-
CBNumber
CB22470849
Molecular Formula
C55H87NO14
Formula Weight
986.28
MOL File
851536-75-9.mol
More
Less

UMiroliMus Property

Boiling point:
991.0±75.0 °C(Predicted)
Density 
1.15±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
form 
A solid
pka
10.40±0.70(Predicted)
color 
White to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
23585
Product name
Umirolimus
Purity
≥95%
Packaging
1mg
Price
$117
Updated
2024/03/01
Cayman Chemical
Product number
23585
Product name
Umirolimus
Purity
≥95%
Packaging
5mg
Price
$463
Updated
2024/03/01
TRC
Product number
U710005
Product name
Umirolimus
Packaging
5mg
Price
$370
Updated
2021/12/16
TRC
Product number
U710005
Product name
Umirolimus
Packaging
1mg
Price
$85
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0007715
Product name
UMIROLIMUS
Purity
95.00%
Packaging
5MG
Price
$504
Updated
2021/12/16
More
Less

UMiroliMus Chemical Properties,Usage,Production

Description

Coronary stents have dramatically improved the success rate of interventional cardiology in recent years, and stent implantation has become the standard of care in percutaneous coronary interventions. However, the long-term success of coronary stenting is hampered by a high rate of restenosis (i.e., recurrence of stenosis, or reblocking), which is caused by proliferation and migration of smooth muscle cells and production of extracellular matrix. The Biomatrix DES is a novel stent system combining a biodegradable PLA and the new anti-restenoic drug biolimus. Biolimus is a semi-synthetic analog of sirolimus wherein the hydroxyl moiety at position 42 is modified to an ethoxyethyl ether group. As with rapamycin, the mechanism of action of biolimus consists of forming a complex with intracellular 12-kDa FK506-binding protein (FKBP-12), which binds to the mammalian target of rapamycin (mTOR) and reversibly inhibits cell-cycle transition of proliferating smooth muscle cells.The antiproliferative potency of biolimus is similar to that of sirolimus; however, it is approximately 10-fold more lipophilic than sirolimus, which results in rapid absorption of the drug into fatty tissues and reduced systemic exposure. The Biomatrixs DES is produced by the absorption of a 1:1 combination of biolimus and PLA on a flexible stainless steel stent. The precision automated coating method used in the production of the stent ensures the PLA biolimus combination is applied solely to the abluminal surface of the stent. PLA is co-released with biolimus over 6 9 months, and biodegraded initially to lactic acid, and eventually to carbon dioxide and water.

Originator

Biosensors (United States)

Uses

Umirolimus is one of two promising agents for the treatment of peripheral artery disease (PAD) and minimize restenosis. Umirolimus is a medical device to suppress localised immunoreaction.

Uses

Umirolimus is a semi-synthetic macrocyclic lactone prepared from rapamycin by selective alkylation of the 42-hydroxy group, providing one of most hydrophobic tacrolimus analogues. Umirolimus has been targeted for use in stents and medical devices to suppress localised immunoreaction. Like all tacrolimus analogues, umirolimus binds to receptor protein, FKBP12. The complex then binds to mTOR and prevents it from interacting with target proteins. Umirolimus is extensively cited in the literature with over 70 citations.

brand name

Biomatrix

Synthesis

The synthesis involves the preparation of the ethoxyethyl triflate 18 which was obtained by reacting ethoxyethanol 17 with triflic anhydride in dichloromethane in the presence of 2,6-lutidine at 0 ??C. Selective alkylation of rapamycin 19 alcohol at C-42 with crude triflate 18 in a mixture of toluene and 2,6-lutidine at 60 ??C gave biolimus A9 II in 25% isolated yield.

UMiroliMus Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

UMiroliMus Suppliers

ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18110
Advantage
56
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Lynnchem
Tel
86-(0)29-85992781 17792393971
Email
info@lynnchem.com
Country
China
ProdList
4587
Advantage
58
Wuhan FengyaoTonghui Chemical Products Co., Ltd.
Tel
027-87466105 15377573527
Email
2678564200@qq.com
Country
China
ProdList
17987
Advantage
58
Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
Country
China
ProdList
6777
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 +86-13028896684;
Email
sales@rrkchem.com
Country
China
ProdList
57422
Advantage
58
Taizhou Crene Biotechnology Co. Ltd.
Tel
+86-0576-88813233 +86-13396860566
Email
sales@pharm-intermediates.com
Country
China
ProdList
1991
Advantage
58
Shanghai Fuyi Biological Technology Co., Ltd.
Tel
18096642264
Email
sales@foreversyn.com
Country
China
ProdList
492
Advantage
58
Hubei Jusheng Technology Co.,Ltd.
Tel
18871490254
Fax
027-59599243
Email
linda@hubeijusheng.com
Country
CHINA
ProdList
28172
Advantage
58
Hefei fuya biotechnology co. LTD
Tel
18096409024
Email
sales02@foreversyn.com
Country
China
ProdList
1910
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
Zhongxin Chenshi (Wuhan) Technology Co., Ltd
Tel
18942922096
Fax
QQ 2662561040
Email
2662561040@qq.com
Country
China
ProdList
1002
Advantage
58
Meng Cheng Technology (Shanghai) Co., LTD
Tel
400-820-6829
Email
sales@mitachieve.com
Country
China
ProdList
8860
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing@energy-chemical.com
Country
China
ProdList
44918
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 15801484223;
Email
psaitong@jm-bio.com
Country
China
ProdList
29774
Advantage
58
Foshan Treasure Biotechnology Co., Ltd
Tel
0757-85921206 18520245316
Email
2329783215@qq.com
Country
China
ProdList
12661
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24641
Advantage
58
Shanghai Maclean Biochemical Technology Co., LTD
Tel
021-50706066 15221275939
Email
shenlinxing@macklin.cn
Country
China
ProdList
30016
Advantage
58
Shanghai Saikerui Biotechnology Co. , Ltd.
Tel
021-58000709 15900491054
Email
info@scrbio.com
Country
China
ProdList
9515
Advantage
58
guoyungurui
Tel
18162595016; 18162595016
Email
3287908757@qq.com
Country
China
ProdList
10335
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12000
Advantage
58
Nantong Hanfang Biotechnology Co. , Ltd.
Tel
18616537568
Email
hanfangpharma@126.com
Country
China
ProdList
29981
Advantage
58
Chengdu Peter-like Biotechnology Co., Ltd.
Tel
028-81700200 13308200041
Email
2851167782@qq.com
Country
China
ProdList
11183
Advantage
58
Shanghai Weiyite Biotechnology Co., Ltd
Tel
15317051735
Email
sales@wytsci.com
Country
China
ProdList
9731
Advantage
58
Shanghai Forever Synthesis Co.,Ltd
Tel
18096642264
Email
sales01@foreversyn.com
Country
China
ProdList
890
Advantage
58
Cayman Chemical Company
Tel
800-3649897
Email
Caymanname@qq.com
Country
China
ProdList
21643
Advantage
58
Pure Research Chemicals
Tel
13564847951 18019592524
Email
info@purerechem.com
Country
China
ProdList
964
Advantage
58
Neobioscience Co., Ltd.
Tel
--
Fax
--
Email
info@neobioscience.com
Country
CHINA
ProdList
6207
Advantage
58

851536-75-9, UMiroliMusRelated Search:


  • BioliMus
  • BioliMus, BioliMus A9, TRM 986
  • BIOLIMUS A9
  • UMiroliMus
  • Rapamycin, 42-O-(2-ethoxyethyl)-
  • BioliMus A9 UMiroliMus
  • TRM 986
  • TRM986
  • TRM-986
  • 851536-75-9
  • C55H87NO14
  • Immunosuppressant
  • API